科微学术
生物工程学报
国家自然科学基金 (Nos. 11247018, 11147175), 四川省教育厅科研重点项目 (No. 12ZA066), 乐山市科技计划项目 (No. 14SZD018) 资助。
- Li Liang
- Jianping Hu
Jianping Hu
1 Key Laboratory of Medicinal and Edible Plants Resources Development of Sichuan Education Department, Sichuan Industrial Institute of Antibiotics, Chengdu University, Chengdu 610106, Sichuan, China; 2 College of Chemistry, Leshan Normal University, Leshan 614004, Sichuan, China
在期刊界中查找
在百度中查找
在本站中查找 - Wenyi Du
- Ke Zuo
- Wei Liu
- Xiaojun Gou
National Natural Science Foundation of China (Nos. 11247018, 11147175), Research Key Project of Sichuan Province Education Department (No. 12ZA066), Leshan Science and Technology Project (No. 14SZD018).
- 摘要 | |
- 访问统计 | |
- 相似文献 | | |
- 文章评论
Faldaprevir类似物 (Faldaprevir analogue molecule, FAM) 能有效抑制HCV NS3/4A蛋白酶的催化活性，是一种潜在抗HCV先导化合物。通过生物信息学统计分析了已报道的HCV NS3/4A 蛋白酶晶体结构，得到了FAM-HCV NS3/4A蛋白酶晶体结构。对FAM-HCV NS3/4A蛋白酶复合物进行了20.4 ns的分子动力学模拟，重点从氢键和结合自由能两个角度分析了二者分子识别中的关键残基及结合驱动力。氢键和范德华力是促使FAM特异性结合到蛋白V132-S139、F154-D168、D79-D81和V55的活性口袋中的主要驱动力，这与实验数据较为吻合。耐药性突变实验分析了R155K、D168E/V和V170T定点突变对FAM分子识别的影响，为可能存在的FAM耐药性提供了分子依据。最后，用自由能曲面和构象聚类两个方法探讨了体系的构象变化，给出体系的4种优势构象，为后续的基于HCV NS3/4A蛋白酶结构的Faldaprevir类似物抑制剂分子设计提供一定的理论帮助。
Faldaprevir analogue molecule (FAM) has been reported to effectively inhibit the catalytic activity of HCV NS3/4A protease, making it a potential lead compound against HCV. A series of HCV NS3/4A protease crystal structures were analyzed by bioinformatics methods, and the FAM-HCV NS3/4A protease crystal structure was chosen for this study. A 20.4 ns molecular dynamics simulation of the complex consists of HCV NS3/4A protease and FAM was conducted. The key amino acid residues for interaction and the binding driving force for the molecular recognition between the protease and FAM were identified from the hydrogen bonds and binding free energy analyses. With the driving force of hydrogen bonds and van der Waals, FAM specifically bind to the active pocket of HCV NS3/4A protease, including V130?S137, F152?D166, D77?D79 and V55, which agreed with the experimental data. The effect of R155K, D168E/V and V170T site-directed mutagenesis on FAM molecular recognition was analyzed for their effect on drug resistance, which provided the possible molecular explanation of FAM resistance. Finally, the system conformational change was explored by using free energy landscape and conformational cluster. The result showed four kinds of dominant conformation, which provides theoretical basis for subsequent design of Faldaprevir analogue inhibitors based on the structure of HCV NS3/4A protease.
引用本文
梁立,胡建平,杜文义,左柯,刘嵬,苟小军. HCV NS3/4A蛋白酶与Faldaprevir类似物的分子识别机制及其复合物运动模式[J]. 生物工程学报, 2016, 32(5): 669-682
复制
文章指标
- 点击次数:1237
- 下载次数: 2068
- HTML阅读次数: 712
历史
- 收稿日期:2015-08-31
- 在线发布日期: 2016-05-04
文章二维码
生物工程学报 ® 2025 版权所有
通信地址：中国科学院微生物研究所 邮编：100101
电话：010-64807509 E-mail：cjb@im.ac.cn
技术支持：北京勤云科技发展有限公司